CTLT Shares Outstanding History
Below is a table of the CTLT shares outstanding history going back to 9/1/2014:

Date CTLT Shares Outstanding
9/1/2014117.32M
11/3/2014123.81M
2/2/2015123.82M
4/30/2015124.29M
9/1/2015124.52M
10/30/2015124.52M
1/29/2016124.52M
4/29/2016124.66M
8/22/2016124.74M
10/31/2016124.75M
1/31/2017124.78M
4/28/2017124.96M
8/24/2017125.18M
11/3/2017132.86M
2/2/2018133.32M
4/27/2018133.37M
8/21/2018144.87M
11/2/2018145.37M
2/1/2019145.63M
5/3/2019145.72M
8/22/2019146.02M
7/23/201939.08M
11/1/2019146.31M
1/31/2020146.42M
5/1/2020154.90M
8/31/2020164.14M
10/29/2020164.70M
1/25/2021170.23M
4/27/2021170.34M
8/23/2021170.79M
10/26/2021171.19M
1/25/2022179.10M
4/26/2022179.21M
8/19/2022179.90M
10/27/2022179.96M

Also see: CTLT Market Cap History
CTLT YTD Return
CTLT RSI
CTLT DMA
CTLT MACD
CTLT Technical Analysis
CTLT Historical Shares Outstanding:
+5.38% CAGR
CTLT Historical Shares Outstanding: +5.38% CAGR

Mouse over chart for data details
9/1/2014 ...10/27/2022
Catalent is a holding company. Through its subsidiaries, Co. has two operating and reporting segments: Biologics and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells; and vaccines. The Pharma and Consumer Health segment comprises Co.'s capabilities for oral solids, softgel formulations, Zydis® fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services. We show 35 historical shares outstanding datapoints in our coverage of CTLT's shares outstanding history.

Understanding the changing numbers of CTLT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CTLT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CTLT by allowing them to research CTLT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CTLT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Catalent (CTLT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CTMX Shares Outstanding History
CTRV Shares Outstanding History
CTSO Shares Outstanding History
CTXR Shares Outstanding History
CUE Shares Outstanding History
CUR Shares Outstanding History
CUTR Shares Outstanding History
CVRX Shares Outstanding History
CVS Shares Outstanding History
CWBR Shares Outstanding History
More Healthcare companies »

 

CTLT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2023, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.